Lacosamide

Cat. No. M1427

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

Erlosamide

Size	Price	Availability
5mg	USD 50 USD50	In stock
10mg	USD 70 USD70	In stock
25mg	USD 120 USD120	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Lacosamide is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.

Molecular Weight	250.29
Formula	C13H18N2O3
CAS Number	175481-36-4
Solubility (25°C)	Soluble in chloroform and methanol
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Sodium Channel Products
5-(N,N-Hexamethylene)-amiloride 5-(N,N-Hexamethylene)-amiloride (Hexamethylene amiloride) is a potent Na+/H+ exchanger inhibitor, which decreases the intracellular pH (pHi) and induces apoptosis in leukemic cells. 5-(N,N-Hexamethylene)-amiloride (Hexamethylene amiloride) is also an inhibitor of the HIV-1 Vpu virus ion channel and inhibits mouse hepatitis virus (MHV) replication and human coronavirus 229E (HCoV229E) replication in cultured L929 cells with EC50s of 3.91 μM and 1.34 μM, respectively.
HwTx-IV Huwentoxin-IV (HwTx-IV) is a 35-residue neurotoxin peptide with potential application as a novel analgesic. Huwentoxin-IV, a component of tarantula venom, potently blocks sodium channels and is an attractive scaffold for engineering a Nav1.7-selective molecule.
ST-2560 ST-2560 is a selective inhibitor of the NaV1.7 sodium channel with IC50 value of 39 nM in primates with ≥1000-fold selectivity over other isoforms of the human NaV1.x family.
A-317567 A-317567 is a potent acid-sensing ion channel 3 (ASIC-3) inhibitor with an IC50 of 1.025 μM.
XPC-6444 XPC-6444 is a highly potent, isoform-selective, and CNS-penetrant NaV1.6 inhibitor (IC50=41 nM for hNaV1.6).

Catalog